Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Vomiting 3Pain 3Nausea 3Neoplasms 2Taste Disorders 1Parasomnias 1Pancreatic Neoplasms 1Olfaction Disorders 1Cancer Pain 1Breast Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Dronabinol × Clear all
NCT00674609 2023-05-03

SPRAY

Jazz Pharmaceuticals

Phase 3 Completed
177 enrolled 21 charts

Neoplasms, Pain

NCT00316563 2010-02-09

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

AHS Cancer Control Alberta

Phase 2 Completed
80 enrolled

Anorexia, Olfaction Disorders, Neoplasms, Taste Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡